Measuring adherence to highly active antiretroviral therapy: implications for research and practice.

被引：28

作者：

Kerr T. ^{[1
]}

Walsh J. ^{[1
]}

Lloyd-Smith E. ^{[1
]}

Wood E. ^{[1
]}

机构：

[1] British, British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver

来源：

Current HIV/AIDS Reports | 2005年 / 2卷 / 4期

关键词：

Medication Adherence; Pill Count; Acquir Immune; Adherence Behavior; Medication Event Monitoring System;

D O I：

10.1007/s11904-005-0017-3

中图分类号：

学科分类号：

摘要：

Highly active antiretroviral therapy (HAART) has radically changed the course of HIV disease, producing substantial reductions in both HIV-related morbidity and mortality. However, the complexity of the typical daily HAART regimen is substantial, and high levels of adherence are essential for complete and long-term viral suppression and the avoidance of drug resistance. The complexity of HAART has made the assessment of medication adherence of paramount importance. Even though various methods are in use, each measures only a subset of adherence behaviors, and each measure has limited predictive validity. Given the individual and public health concerns associated with adherence to HAART, there is a need for the continued development and validation of measures of medication adherence.

引用

页码：200 / 205

页数：5

共 130 条

[1]

Hogg RS(1999)Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens CMAJ 160 659-665

[2]

Yip B(1997)A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team N Engl J Med 337 725-733

[3]

Kully C(1999)Attaining higher goals in HIV treatment: the central importance of adherence AIDS 13 S61-72

[4]

Hammer SM(1998)Measuring HIV treatment adherence in clinical practice AIDS Clin Care 10 57-59

[5]

Squires KE(1997)Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Sydney Primary HIV Infection Study Group J Infect Dis 175 1502-1506

[6]

Hughes MD(2001)Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence J Clin Epidemiol 54 S91-98

[7]

Friedland GH(2002)Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring J Acquir Immune Defic Syndr 30 324-334

[8]

Williams A(2001)A comparison study of multiple measures of adherence to HIV protease inhibitors Ann Intern Med 134 968-977

[9]

Hecht FM(2005)Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis J Acquir Immune Defic Syndr 38 445-448

[10]

Imrie A(2000)Measuring adherence to antiretroviral medications in clinical trials HIV Clin Trials 1 36-46

← 1 2 3 4 5 6 7 8 9 10 →